HALO logo
halo search icon
Alaunos Therapeutics, Inc.

US$2.40

Price Change Indicator
-0.10 (-4.00%)
Alaunos Therapeutics, Inc.
TCRT · NAS

Alaunos Therapeutics, Inc.

Start Trading TCRT for Free

US$2.40

Price Arrow-0.10 (-4.00%)
20/05/2026 04:00:01 PM
All-CompaniesHALO All
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Alaunos Therapeutics, Inc. Overview

TCRT Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About TCRT

icon
icon

Telephone

1.346.355.4099

icon

Address

Suite 300, 501 East Las Olas Boulevard, Fort Lauderdale, FL 33301

Description

Alaunos Therapeutics, Inc. is a biopharmaceutical company and clinical-stage oncology-focused cell therapy company, which engages in the development of adoptive TCR engineered T-cell therapies, or TCR-T, designed to treat multiple solid tumor types in large cancer patient populations with unmet clinical needs. Its pipeline includes Library TCR-T cell and mblL-15 TCR-T cell Therapy. The company was founded in 2003 and is headquartered in Fort Lauderdale, FL.

TCRT Price Chart

Key Stats

Market Cap

US$61.06M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.67 - 6.2

Trade Value (12mth)

US$137,239.00

1 week

1.21%

1 month

-10.07%

YTD

-23.78%

1 year

-1.57%

All time high

3300.00

Key Fundamentals

EPS 3 yr Growth

-91.60%

EBITDA Margin

NaN%

Operating Cashflow

-$3m

Free Cash Flow Return

-136.10%

ROIC

-198.10%

Interest Coverage

0.00

Quick Ratio

2.40

Other Data

Shares Outstanding (Fully Diluted)

2m

HALO Sector

Healthcare

Next Company Report Date

09-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

TCRT Announcements

Latest Announcements

DateAnnouncements
18 May 26
18 May 26
16 May 26
16 May 26
01 May 26

TCRT Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-21.97-2.92-2.2locklocklock
EPS (Fully Diluted)
 $locklocklocklock-21.97-2.92-2.2locklocklock
Growth
 %locklocklocklock15.786.724.8locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Alaunos Therapeutics, Inc. (TCRT:NAS)?
Halo FAQ
The current share price of Alaunos Therapeutics, Inc. (TCRT:NAS) is USD$2.40.
What is the 52-week high share price for Alaunos Therapeutics, Inc. (TCRT:NAS)?
Halo FAQ
The 52-week high share price for Alaunos Therapeutics, Inc. (TCRT:NAS) is USD$6.20.
What is the 52-week low share price for Alaunos Therapeutics, Inc. (TCRT:NAS)?
Halo FAQ
The 52-week low share price for Alaunos Therapeutics, Inc. (TCRT:NAS) is USD$1.67.
What is the dividend yield for Alaunos Therapeutics, Inc. (TCRT:NAS)?
Halo FAQ
Alaunos Therapeutics, Inc. (TCRT:NAS) does not pay a dividend.
What was Alaunos Therapeutics, Inc. (TCRT:NAS) last dividend payment?
Halo FAQ
Alaunos Therapeutics, Inc. (TCRT:NAS) does not pay a dividend.
What is the franking level for Alaunos Therapeutics, Inc. (TCRT:NAS)?
Halo FAQ
Alaunos Therapeutics, Inc. (TCRT:NAS) has a franking level of 0.00%.
In which sector is Alaunos Therapeutics, Inc. (TCRT:NAS) classified?
Halo FAQ
Alaunos Therapeutics, Inc. (TCRT:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial